Evasion of host immune responses by tumours and viruses
- PMID: 7796674
- DOI: 10.1002/9780470514672.ch16
Evasion of host immune responses by tumours and viruses
Abstract
Viruses and tumours use various mechanisms to avoid immune surveillance. Oncogenic viruses have achieved a balance with the immune system through evolutionary time to ensure long-term persistence. Mutations that promote escape mechanisms favouring tumour growth to the detriment of host survival through reproductive age offer no selective advantage and will not generally be maintained in the viral genome that persists in nature. Conventional (non-oncogenic) and tumour viruses interact with various immune mediators and T cells in different ways. Oncogenic viruses cannot operate solely in the context of a lytic cycle, though this may be characteristic of the initial phase of infection that is limited by the acute immune response. Some oncogenic viruses interact with normal cellular growth control and signalling mechanisms. Synthesis of key viral proteins may be tightly controlled in replicating cells that are subject to T cell surveillance, such as basal epithelia, while productive infection occurs in non-proliferating progeny that are lost under normal physiological conditions, such as desquamating epithelia. Tumorigenesis may be an aberrant consequence of the molecular mechanisms needed to maintain this pattern of viral growth regulation in the context of the cell cycle. Vaccines designed to limit the acute phase of infection with cell-free oncogenic viruses should be as effective as those for conventional viruses.
Similar articles
-
Immune response to tumour antigens.Trans Ophthalmol Soc U K (1962). 1977 Sep;97(3):381-4. Trans Ophthalmol Soc U K (1962). 1977. PMID: 347640 Review.
-
Human Adenovirus Core Protein V Is Targeted by the Host SUMOylation Machinery To Limit Essential Viral Functions.J Virol. 2018 Jan 30;92(4):e01451-17. doi: 10.1128/JVI.01451-17. Print 2018 Feb 15. J Virol. 2018. PMID: 29167340 Free PMC article.
-
Human cancers and viruses: a hypothesis for immune destruction of tumours caused by certain enveloped viruses using modified viral antigens.Med Hypotheses. 1992 Sep;39(1):17-21. doi: 10.1016/0306-9877(92)90134-x. Med Hypotheses. 1992. PMID: 1435387
-
Replicating adenoviruses in cancer therapy.Curr Top Microbiol Immunol. 2004;273:291-334. doi: 10.1007/978-3-662-05599-1_9. Curr Top Microbiol Immunol. 2004. PMID: 14674605 Review.
-
Influenza A Virus Protein PA-X Contributes to Viral Growth and Suppression of the Host Antiviral and Immune Responses.J Virol. 2015 Jun;89(12):6442-52. doi: 10.1128/JVI.00319-15. Epub 2015 Apr 8. J Virol. 2015. PMID: 25855745 Free PMC article.
Cited by
-
Chronic immune activation and inflammation as the cause of malignancy.Br J Cancer. 2001 Aug 17;85(4):473-83. doi: 10.1054/bjoc.2001.1943. Br J Cancer. 2001. PMID: 11506482 Free PMC article. Review.
-
Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells.J Exp Med. 1996 Sep 1;184(3):863-71. doi: 10.1084/jem.184.3.863. J Exp Med. 1996. PMID: 9064346 Free PMC article.
-
Predicting viral proteins that evade the innate immune system: a machine learning-based immunoinformatics tool.BMC Bioinformatics. 2024 Nov 9;25(1):351. doi: 10.1186/s12859-024-05972-7. BMC Bioinformatics. 2024. PMID: 39522017 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources